In The News
Judge slashes contingency fee in Insurance Australia class action
ExxonMobil sues Andrew Forrest-linked NGO for defamation
Tenth junior doctors class action filed after run of court wins
Foxtel wins opposition to ‘originals IQ’ trade mark
BHP’s Mt Arthur Coal not permitted to conduct ‘trial by ambush’ in injury case
GM hit with class action over allegedly defective Holden transmissions
Another judge overturns decision for uncritical copying and pasting
Jetstar hits back at class action over COVID-19 flight credits
Exactech class action continues settlement talks despite US bankruptcy
Baker McKenzie partner returns from Hogan Lovells
Please login to bookmarkClose

A judge has denied Sanofi’s bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established a strong enough case of infringement to justify granting the injunction.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au